My research expertise is in the area of geriatric pharmacoepidemiology. Pharmacoepidemiology employs the methods of epidemiology to study outcomes of drug treatments in specific populations in real-world settings. The group has collaborations with centres in Christchurch (Big Data and Better Ageing Research Group, University of Otago, Christchurch) and researchers based at The University of Sydney, University of Queensland, Monash University & Yale University. The research group also has collaborations and support from The Ministry of Health, New Zealand. The group positioned along the translational axis delivers high-quality research that has a considerable impact on medicines policy and practice.

I am interested to recruit doctoral students. Current projects on offer:

1. Development and validation of a novel anticholinergic tool to quantify anticholinergic burden.

2. Novel pharmacoepidemiological approaches to predict adverse drug reactions.

3. Measuring the impact of drug burden and polypharmacy on health outcomes in older people.

4. Deprescribing medicines with limited time-until-benefit in older people.

5. Measuring the impact of the anticholinergic burden on health outcomes in individuals with dementia.